Covidien, a leading global provider of healthcare products, today announced that its Surgical Devices business unit has introduced the VascuSeal Vascular Sealant System throughout Europe and in select Middle East markets. VascuSeal offers surgeons a unique advanced hydrogel that provides an immediate, blood-tight seal that is effective intraoperatively and throughout the critical healing period. VascuSeal, [...]

Continue reading " VascuSeal Vascular Sealant System "

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the publication of a study in the Journal of Interferon & Cytokine Research by scientists at Alnylam Europe (now Roche Kulmbach), and collaborators, further delineating the mechanisms whereby some siRNAs can trigger immunostimulatory effects in mammalian cells. In addition, this research demonstrates the [...]

Continue reading " Alnylam and Collaborators Publish Research on the Immunostimulatory Properties and Mechanisms of Certain siRNAs in Mammalian Cells "

Sorin Group (MIL:SRN) Cardiac Rhythm Management announced today the first implant in a clinical trial of its new-generation PARADYM 8770 sonR cardiac resynchronization therapy defibrillator (CRT-D). This system contains a unique technology named sonR designed to adjust CRT delivery based on hemodynamic response as opposed to conventional CRT-D devices, that monitor the electrical activity of [...]

Continue reading " First Implant of a New-Generation CRT-D Device "